Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

mark_7i8a2

Community Contributor

Member since 2020

Views

Fair Values Set

Comments

Followers

No bio added yet

No link added

SPRY·13 days agoWhy the Market is Wrong About the ARS Pharma vs. Aquestive "DUOPOLY"

You're not even factoring in the primary challenger. Belhaven Pharma's product has better temperature control, faster time to onset and is more stable than either of the two you are tracking. Their product Nasdepi will become the incumbent over the Epipen....